Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 2- Ramipril Arm) Posted: Thursday, September 21, 2006

The Dream Study also found that the ACE-inhibitor Altace (ramipril) does not prevent type 2 diabetes in patients with impaired glucose metabolism.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 1-Rosiglitazone Arm) Posted: Thursday, September 21, 2006

The results of a major study released: The Dream Study (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) with over 5000 patients Rosiglitazone reduced the risk of developing type 2 diabetes by 62 percent (p<0.0001) relative to placebo among people at high risk of developing type 2 diabetes.

Significant Glucose-Lowering Efficacy Of JANUVIA™ in Phase III Study Posted: Thursday, September 21, 2006

New data presented for the first time at the 42nd annual meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen demonstrated a mean reduction in A1C of 2.1% from a mean baseline A1C of 8.8% and a reduction of 2.9% for those with a mean A1c of 11.2%.

New Hypertension Pills Cut Diabetes Risk by A Third Posted: Thursday, September 21, 2006

Researchers have reported that patients given a specific combination of new blood pressure drugs are one-third less likely to develop diabetes than those on older pills.

Galvus® Demonstrates Powerful Blood Sugar Reductions In Phase III Studies Posted: Thursday, September 21, 2006

Galvus dropped A1c by 1.8% without weight gain.

Steroids Trial Beats Diabetes Blindness Posted: Wednesday, September 13, 2006

Australian research has proven the effectiveness of a steroid treatment for a type of diabetic blindness.

Adherence to Preventive Medications Reduces Risk of Diabetes Posted: Wednesday, September 13, 2006

Participants who were compliant had a 38.2% reduced risk of developing diabetes.

University of VA Finds Possible Diabetes Cure Posted: Thursday, September 07, 2006

After two years of work Dr. Jerry Nadler has successfully reversed the course of type 1 Diabetes.

Blacks Have Poorer Control of Diabetes Than Whites Posted: Thursday, August 31, 2006

A new review of the data from 56,000 patients shows that blacks with diabetes tend to have worse control of the disease than whites.

Prandin Offers Advantages in Elderly Diabetics Posted: Thursday, August 17, 2006

Fifty-one percent risk reduction for hypoglycemia over glyburide in elderly patients with type 2 or non-insulin dependent diabetes, treatment with the short-acting drug repaglinide (Prandin/NovoNorm).

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.